- The report features Sage Therapeutics , Inc .' s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons To Buy - Evaluate Sage Therapeutics , Inc .' s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information , analysis , and insights to formulate effective R & D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Sage Therapeutics , Inc . - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Sage Therapeutics , Inc .' s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Buy a Sample copy of This Report @ http :// www . radiantinsights . com / research / sage-therapeutics-inc-productpipeline-review-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Sage Therapeutics , Inc . Snapshot 5 Sage Therapeutics , Inc . Overview 5 Key Information 5 Key Facts 5 Sage Therapeutics , Inc . - Research and Development Overview 6 Key Therapeutic Areas 6 Sage Therapeutics , Inc . - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Sage Therapeutics , Inc . - Pipeline Products Glance 11 Sage Therapeutics , Inc . - Late Stage Pipeline Products 11 Phase III Products / Combination Treatment Modalities 11 Sage Therapeutics , Inc . - Clinical Stage Pipeline Products 12 Phase II Products / Combination Treatment Modalities 12 Phase I Products / Combination Treatment Modalities 13 Sage Therapeutics , Inc . - Early Stage Pipeline Products 14 IND / CTA Filed Products / Combination Treatment Modalities 14 Preclinical Products / Combination Treatment Modalities 15 Discovery Products / Combination Treatment Modalities 16 Sage Therapeutics , Inc . - Drug Profiles 17 sepranolone 17 Product Description 17 Mechanism of Action 17 R & D Progress 17 SAGE-217 20 Product Description 20 Mechanism of Action 20 R & D Progress 20